BridgeMD
The Colder Fluids Study
EU CTIS ID: 2023-506018-35-00
What this study is testing
This randomized controlled crossover study investigates the effect of Ringer's lactate solution at high and low temperatures on physiological response in healthy adults.
- Human Pharmacology (Phase I)- Other
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age between 18-64
You likely can't join if
- Pre-existing medical problems that are contraindicated for cold crystalloid infusions
- Pregnancy (validated through a certified urine pregnancy test)
- Body mass index >35 kg/m2
- Medication use, including over-the-counter anti-pyretics within 48 hours, with exception of allergy medication and contraceptives.
- Any family history or predisposition of coagulopathies
- Any intake of inhibitors of 11β-Hydroxysteroid dehydrogenase the past 48 hours (products containing liquorice)
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.